The Chinese STEMI PPCI Registry (CSPR)
The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry
1 other identifier
observational
5,594
1 country
1
Brief Summary
The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 22, 2021
CompletedFirst Submitted
Initial submission to the registry
July 27, 2021
CompletedFirst Posted
Study publicly available on registry
August 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2021
CompletedDecember 20, 2021
December 1, 2021
7 months
July 27, 2021
December 9, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
in-hospital acute de novo heart failure
Killip class ≥II
in-hospital outcome, until discharge
cardiogenic shock
according to the universal definition
in-hospital outcome, until discharge
death
according to the universal definition
in-hospital outcome, until discharge
Study Arms (2)
derivation cohort
Data from Renmin Hospital of Wuhan University, The First College of Clinical Medical Science, China Three Gorges University, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Xiangyang No.1 People's Hospital,and Wuhan Third Hospital will be used as a derivation cohort.
validation cohort
Data from The First Affiliated Hospital of Dalian Medical University and Jiangxi Provincial People's Hopital will be used as a derivation cohort.
Interventions
Eligibility Criteria
All patients with STEMI were treated by primary percutaneous coronary intervention at 7 large centers from central China.
You may qualify if:
- Age≥18
- ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction
- STEMI treated by pPCI
You may not qualify if:
- Patient with heart failure in admission
- STEMI with symptom-onset-to-balloon time\>24h
- pPCI was not successful or only underwent coronary angiography
- Killip class ≥II in admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Renmin Hospital of Wuhan Universitylead
- The First College of Clinical Medical Science, China Three Gorges Universitycollaborator
- The First Affiliated Hospital of Dalian Medical Universitycollaborator
- Jiangxi Provincial People's Hopitalcollaborator
- The Central Hospital of Enshi Tujia And Miao Autonomous Prefecturecollaborator
- Xiangyang No.1 People's Hospitalcollaborator
- Wuhan Third Hospitalcollaborator
Study Sites (1)
Renmin Hospital of Wuhan university
Wuhan, Hubei, 430000, China
Related Publications (4)
Xu J, Luo D, Lei Y, Hu Z, Tian H, Chen X, Zhou W, Li M, Liu S, Jin X, Wang Y, Zhang B, Zhou Q, Chen J. Correlation between abnormal microvascular perfusion and quantitative flow ratio after primary PCI in patients with STEMI. Int J Cardiol. 2025 Mar 1;422:132949. doi: 10.1016/j.ijcard.2024.132949. Epub 2024 Dec 31.
PMID: 39746473DERIVEDWang H, Yang Y, Zeng P, Huang R, Cai X, Shao L, Liu F, Lei Y, Li D, Fan Z, Yang J, Zhang J, Yang J. Association between Systemic Immune-Inflammation Index (SII) and New-Onset In-Hospital Heart Failure in Patients with STEMI after Primary PCI. Rev Cardiovasc Med. 2024 Oct 24;25(10):382. doi: 10.31083/j.rcm2510382. eCollection 2024 Oct.
PMID: 39484131DERIVEDHu Z, Luo D, Zhou WJ, Xu CW, Chen XZ, Zhang BF, Jin X, Wang Y, Zhang J, Wu H, Liu FY, Lei YH, Li DS, Cai XY, Jiang H, Chen J. Association between admission blood pressure and spontaneous reperfusion and long-term prognosis in STEMI patients: an observational and multicenter study. BMC Cardiovasc Disord. 2024 Sep 18;24(1):500. doi: 10.1186/s12872-024-04168-4.
PMID: 39294617DERIVEDLuo D, Huang R, Wang X, Zhang J, Cai X, Liu F, Lei Y, Li D, Zhou W, Xu C, Huang B, Jiang H, Chen J. INTRA-AORTIC BALLOON PUMP REDUCES 30-DAY MORTALITY IN EARLY-STAGE CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION ACCORDING TO SCAI CLASSIFICATION. Shock. 2023 Sep 1;60(3):385-391. doi: 10.1097/SHK.0000000000002184. Epub 2023 Aug 4.
PMID: 37548623DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Liwei Cheng
Renmin Hospital of Wuhan University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2021
First Posted
August 9, 2021
Study Start
May 22, 2021
Primary Completion
December 5, 2021
Study Completion
December 5, 2021
Last Updated
December 20, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share